邮件订阅 RSS
张家齐, 刘磊, 王桂阁, 白文梁, 李单青. 非小细胞肺癌跳跃性N2淋巴结转移的临床病理特点及预后[J]. 协和医学杂志, 2019, 10(3): 272-277. DOI: 10.3969/j.issn.1674-9081.2019.03.015
引用本文: 张家齐, 刘磊, 王桂阁, 白文梁, 李单青. 非小细胞肺癌跳跃性N2淋巴结转移的临床病理特点及预后[J]. 协和医学杂志, 2019, 10(3): 272-277. DOI: 10.3969/j.issn.1674-9081.2019.03.015
shu
Jia-qi ZHANG, Lei LIU, Gui-ge WANG, Wen-liang BAI, Shan-qing LI. Clinical Pathological Features and Prognosis of Non-small Cell Lung Cancer with Skip N2 Lymph Node Metastasis[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(3): 272-277. DOI: 10.3969/j.issn.1674-9081.2019.03.015
Citation: Jia-qi ZHANG, Lei LIU, Gui-ge WANG, Wen-liang BAI, Shan-qing LI. Clinical Pathological Features and Prognosis of Non-small Cell Lung Cancer with Skip N2 Lymph Node Metastasis[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(3): 272-277. DOI: 10.3969/j.issn.1674-9081.2019.03.015
shu

非小细胞肺癌跳跃性N2淋巴结转移的临床病理特点及预后

Clinical Pathological Features and Prognosis of Non-small Cell Lung Cancer with Skip N2 Lymph Node Metastasis

    摘要
  • 摘要: 肺癌作为全球肿瘤致死的首要原因, 发病率逐年上升。其主要治疗方式, 尤其对于早期非小细胞肺癌患者, 手术治疗依然占主导地位, 而淋巴结转移状态对于肺癌的分期、预后至关重要。跳跃性N2淋巴结转移比较常见, 且与患者预后密切相关。本文主要归纳非小细胞肺癌跳跃性N2淋巴结转移的临床病理特点及其预后, 以期为临床决策提供一定指导。

     

    Abstract: Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death in the world. The main treatment is surgery intervention, especially for the early-stage of NSCLC. The pathological lymph node metastasis is closely associated with the staging and prognosis of patients. Among N2 metastasis, skip N2 metastasis is a quite common phenomenon with a better prognosis. The aim of this article is to summarize the clinical pathological features and prognosis of NSCLC with skip N2 metastasis and to guide the clinical decision making.

     

    • HTML全文
    • 参考文献(45)
    • 相关文章
    • 施引文献
  • 资源附件(0)

/

返回文章
返回